Viewing nowPentine Tablet (Phendimetrazine Tartrate)
Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Daehan New Pharm Co., Ltd.

MFDS item code 200604157 · Approved 2006.03.06
Short-term weight loss adjunct therapy for obesity (including high body mass index and risk factors)
This medication is used for patients with obesity who do not respond to dietary and exercise regimens for weight loss. It is particularly effective for those with a body mass index (BMI) of 30 kg/m2 or higher, or a BMI of 27 kg/m2 or higher with risk factors such as hypertension, diabetes, or dyslipidemia. This drug is utilized as a short-term adjunctive treatment for exogenous obesity that involves calorie intake restriction. It is important to use this medication alone without combining it with other appetite suppressants. It is used to assist with weight loss and improve health risks associated with obesity.
Adults: Administer 35 mg of Phendimetrazine Tartrate orally 2 to 3 times daily, 1 hour before meals. The dose should use the minimum effective amount and be adjusted individually to obtain an appropriate response. For some patients, a single daily dose of 17.5 mg may be appropriate. The dosage should not exceed 70 mg at a time or exceed 3 times a day. This medication is to be taken for a short duration (within 4 weeks).
This medication should not be used in conjunction with other appetite suppressants, as it can lead to severe heart problems. It should only be used alone for short-term weight control and is not safe when combined with other weight loss medications. Long-term use of this medication can significantly increase the risk of serious diseases such as pulmonary arterial hypertension, so if breathing difficulties or heart-related symptoms occur, it should be discontinued immediately and an examination should be conducted. There is also a risk of heart diseases such as valvular heart disease, so it is advisable to consider a heart examination before starting the medication, and those with pre-existing heart issues should avoid using it. This medication should not be administered to patients with certain conditions or those taking specific medications, and caution is particularly warranted in cases of heart disease, hypertension, hyperthyroidism, glaucoma, or mental anxiety. It is prohibited for use in individuals under the age of 16 or pregnant women. As this medication acts on the central nervous system, care should be taken when driving or operating machinery, and diabetic patients may need to adjust their insulin dosage. Abrupt discontinuation after long-term high-dose use can lead to severe fatigue and depression, so it should be tapered off gradually. In cases of overdose, serious symptoms such as anxiety, coma, or seizures may occur, requiring immediate emergency treatment. It should be stored out of reach of children and is classified as a controlled substance, so it should be used according to the physician's prescription and instruction. Women who are pregnant or planning to become pregnant should not use this medication, as the risks to the fetus may be harmful. Caution is also necessary during breastfeeding, as the medication may be transmitted through breast milk. This medication has not established safety and efficacy in pediatric patients under 16 years old, so its use is not recommended.
Hives, peripheral edema, suspected symptoms of pulmonary arterial hypertension (exercise-related dyspnea, angina symptoms, syncope, edema)
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. It should be kept at room temperature, ideally between 1°C and 30°C, avoiding extremely hot or cold locations.
White round tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPhendimetrazine Tartrate 35mg
Tablet · Prescription medication
Daehan New Pharm Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Albuzene Korea Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Joah Pharmaceutical Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Bionex Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
PharmGen Science Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Dae Won Pharmaceutical Co., Ltd.

Phendimetrazine Tartrate 35mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.